DeepCrystal

San Francisco, United States Founded: 2014 • Age: 12 yrs Acquired By Numerate
AI-based geometric learning tools are provided for pharmaceutical applications.

About DeepCrystal

DeepCrystal is a Healthcare company based in San Francisco (United States) founded in 2014, and was acquired by Numerate in October 2017. AI-based geometric learning tools are provided for pharmaceutical applications. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Diversified and Life Sciences. Its competitors include Veeva Systems, Strateos and Instem; 2 of its 3 listed competitors have raised funding.

Company details

DeepCrystal was founded in 2014 and is headquartered in San Francisco, United States. Focus is placed on the pharmaceutical sector, where AI-based geometric learning tools are developed to support drug discovery and molecular analysis. Operations involve computational modeling and data processing services tailored for industry research needs. Geographic presence is centered in the U.S., with tools integrated into pharmaceutical workflows for enhanced efficiency.

Key Metrics

Investors in DeepCrystal

DeepCrystal has secured backing from 1 investor. Prominent investors backing the company include Numerate.

All
InvestorDescriptionFounded YearDomainLocation
Machine-learning algorithms are utilized for small-molecule drug design.
2007numerate.comSan Bruno, United States
Premium access

Investor details for DeepCrystal

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of DeepCrystal

2 dated milestones of DeepCrystal across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded DeepCrystal is founded.
  2. Exit Acquired by Numerate.

Competitors of DeepCrystal

DeepCrystal has 3 listed competitors in our database, 2 of them funded. They include Veeva Systems, Strateos and Instem.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
veeva.com2007Pleasanton, United States$4M226
Cloud-based data management solutions for healthcare are provided.
strateos.com2019Menlo Park, United States$72.6M147
Provider of cloud based platform provides data driven information for biotech research
instem.com1969Conshohocken, United States190
Software for life science data collection and analysis is provided.
Premium access

Detailed competitors of DeepCrystal

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as DeepCrystal (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Deepcrystal

Premium access

Complete news archive for DeepCrystal

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DeepCrystal

DeepCrystal was founded in 2014.

DeepCrystal is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

DeepCrystal was founded in 2014 and is headquartered in San Francisco, United States. Focus is placed on the pharmaceutical sector, where AI-based geometric learning tools are developed to support drug discovery and molecular analysis. Operations involve computational modeling and data processing services tailored for industry research needs. Geographic presence is centered in the U.S., with tools integrated into pharmaceutical workflows for enhanced efficiency.

DeepCrystal's top competitors include Veeva Systems, Instem and Strateos.

DeepCrystal has 1 investor. Key investors include Numerate.

Yes. DeepCrystal was acquired by Numerate in October 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available